Unmet needs for management of drug-resistant infections: low- and middle-income countries’ viewpoint

Monica Sharma; Kamini Walia; Nitin Bansal

doi:10.33393/dti.2022.2532

Authors

Monica Sharma Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi - India https://orcid.org/0000-0001-5389-1669
Kamini Walia Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi, India https://orcid.org/0000-0002-1494-6919
Nitin Bansal Rajiv Gandhi Cancer Institute and Research Centre, New Delhi - India https://orcid.org/0000-0001-5403-6293

DOI:

https://doi.org/10.33393/dti.2022.2532

Keywords:

Antibiotic, Antimicrobial resistance, Diagnostics, India, Infection, Low- and middle-income countries

Abstract

Drug-resistant infections are a serious threat globally which demands cost-effective solutions to meet the unmet needs in their diagnosis and treatment. Gram-negative pathogens, drug-resistant tuberculosis, and multidrugresistant Salmonella typhi have been reported as cause of resistant infections in developing countries. Here, we discuss the priority pathogens and conditions for which feasible solutions adaptable to low-resource settings are required to address the antimicrobial resistance in pathogens. These solutions will be helpful in containing the spread of antimicrobial resistance and better patient outcomes.

Downloads

Download data is not yet available.

References

Murray CJL, Ikuta KS, Sharara F, et al; Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629-655. https://doi.org/10.1016/S0140-6736(21)02724-0 PMID:35065702 DOI: https://doi.org/10.1016/S0140-6736(21)02724-0

Report A. Antimicrobial Resistance Research and Surveillance Network. Indian Council of Medical Research; 2021, Available from https://main.icmr.nic.in/sites/default/files/guidelines/AMRSN_annual_report_2020.pdf.

Veeraraghavan B, Pragasam AK, Ray P, et al. Evaluation of Antimicrobial Susceptibility Profile in Salmonella Typhi and Salmonella Paratyphi A: Presenting the Current Scenario in India and Strategy for Future Management. J Infect Dis. 2021;224(suppl 5):S502-S516. https://doi.org/10.1093/infdis/jiab144 PMID:35238369 DOI: https://doi.org/10.1093/infdis/jiab144

Gandra S, Tseng KK, Arora A, et al. The Mortality Burden of Multidrug-resistant Pathogens in India: A Retrospective, Observational Study. Clin Infect Dis. 2019;69(4):563-570. https://doi.org/10.1093/cid/ciy955 PMID:30407501 DOI: https://doi.org/10.1093/cid/ciy955

Iskandar K, Molinier L, Hallit S, et al. Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture. Antimicrob Resist Infect Control. 2021;10(1):63. https://doi.org/10.1186/s13756-021-00931-w PMID:33789754 DOI: https://doi.org/10.1186/s13756-021-00931-w

Jajoo M, Manchanda V, Chaurasia S, et al; Investigators of the Delhi Neonatal Infection Study (DeNIS) collaboration, New Delhi, India. Alarming rates of antimicrobial resistance and fungal sepsis in outborn neonates in North India. PLoS One. 2018;13(6):e0180705. https://doi.org/10.1371/journal.pone.0180705 PMID:29953451 DOI: https://doi.org/10.1371/journal.pone.0180705

Kumar SG, Adithan C, Harish BN, Sujatha S, Roy G, Malini A. Antimicrobial resistance in India: A review. J Nat Sci Biol Med. 2013;4(2):286-291. https://doi.org/10.4103/0976-9668.116970 PMID:24082718 DOI: https://doi.org/10.4103/0976-9668.116970

Kaur A, Gandra S, Gupta P, Mehta Y, Laxminarayan R, Sengupta S. Clinical outcome of dual colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A single-center retrospective study of 75 cases in India. Am J Infect Control. 2017;45(11):1289-1291. https://doi.org/10.1016/j.ajic.2017.06.028 PMID:28807425 DOI: https://doi.org/10.1016/j.ajic.2017.06.028

Laxminarayan R, Chaudhury RR. Antibiotic Resistance in India: Drivers and Opportunities for Action. PLoS Med. 2016;13(3):e1001974. https://doi.org/10.1371/journal.pmed.1001974PMID:26934098 DOI: https://doi.org/10.1371/journal.pmed.1001974

O’Neil J. Tackling drug-resistant infections globally: final report and recommendations. The review on antimicrobial resistance chaired by Jim O’Neill. Wellcome Trust; London, United Kingdom: 2016; 1: 84. Online https://wellcomecollection.org/works/thvwsuba (Accessed November 2022)

Pokharel S, Raut S, Adhikari B. Tackling antimicrobial resistance in low-income and middle-income countries. BMJ Glob Health. 2019;4(6):e002104. https://doi.org/10.1136/bmjgh-2019-002104 PMID:31799007 DOI: https://doi.org/10.1136/bmjgh-2019-002104

Marchello CS, Carr SD, Crump JA. A Systematic Review on Antimicrobial Resistance among Salmonella Typhi Worldwide. Am J Trop Med Hyg. 2020;103(6):2518-2527. https://doi.org/10.4269/ajtmh.20-0258 PMID:32996447 DOI: https://doi.org/10.4269/ajtmh.20-0258

Mathur P, Malpiedi P, Walia K, et al; Indian Healthcare Associated Infection Surveillance Network collaborators. Health-care-associated bloodstream and urinary tract infections in a network of hospitals in India: a multicentre, hospital-based, prospective surveillance study. Lancet Glob Health. 2022;10(9):e1317-e1325. https://doi.org/10.1016/S2214-109X(22)00274-1PMID:35961355 DOI: https://doi.org/10.1016/S2214-109X(22)00317-5

Wen SCH, Ezure Y, Rolley L, et al. Gram-negative neonatal sepsis in low- and lower-middle-income countries and WHO empirical antibiotic recommendations: A systematic review and meta-analysis. PLoS Med. 2021;18(9):e1003787. https://doi.org/10.1371/journal.pmed.1003787PMID:34582466 DOI: https://doi.org/10.1371/journal.pmed.1003787

Sharma A, Singh A, Dar MA, et al. Menace of antimicrobial resistance in LMICs: current surveillance practices and control measures to tackle hostility. J Infect Public Health. 2022;15(2):172-181. https://doi.org/10.1016/j.jiph.2021.12.008 PMID:34972026 DOI: https://doi.org/10.1016/j.jiph.2021.12.008

Sharma M, Gangakhedkar RR, Bhattacharya S, Walia K. Understanding complexities in the uptake of indigenously developed rapid point-of-care diagnostics for containment of antimicrobial resistance in India. BMJ Glob Health. 2021;6(9):e006628. https://doi.org/10.1136/bmjgh-2021-006628 PMID:34580070 DOI: https://doi.org/10.1136/bmjgh-2021-006628

Sulis G, Sayood S, Gandra S. Antimicrobial resistance in low- and middle-income countries: current status and future directions. Expert Rev Anti Infect Ther. 2022;20(2):147-160. https://doi.org/10.1080/14787210.2021.1951705 PMID:34225545 DOI: https://doi.org/10.1080/14787210.2021.1951705

van Belkum A, Bachmann TT, Lüdke G, et al; JPIAMR AMR-RDT Working Group on Antimicrobial Resistance and Rapid Diagnostic Testing. Developmental roadmap for antimicrobial susceptibility testing systems. Nat Rev Microbiol. 2019;17(1):51-62. https://doi.org/10.1038/s41579-018-0098-9 PMID:30333569 DOI: https://doi.org/10.1038/s41579-018-0098-9

Wahl B, O’Brien KL, Greenbaum A, et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15. Lancet Glob Health. 2018;6(7):e744-e757. https://doi.org/10.1016/S2214-109X(18)30247-X PMID:29903376 DOI: https://doi.org/10.1016/S2214-109X(18)30247-X